Cargando…
Inhibitory efficiency of potential drugs against SARS-CoV-2 by blocking human angiotensin converting enzyme-2: Virtual screening and molecular dynamics study
Till date millions of people are infected by SARS-CoV-2 throughout the world, while no potential therapeutics or vaccines are available to combat this deadly virus. Blocking of human angiotensin-converting enzyme 2 (ACE-2) receptor, the binding site of SARS-CoV-2 spike protein, an effective strategy...
Autores principales: | Khan, Abdul Ashik, Baildya, Nabajyoti, Dutta, Tanmoy, Ghosh, Narendra Nath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845504/ https://www.ncbi.nlm.nih.gov/pubmed/33524563 http://dx.doi.org/10.1016/j.micpath.2021.104762 |
Ejemplares similares
-
Inhibitory effect of anti-HIV compounds extracted from Indian medicinal plants to retard the replication and transcription process of SARS-CoV-2: an insight from molecular docking and MD-simulation studies
por: Dutta, Tanmoy, et al.
Publicado: (2021) -
Inhibitory capacity of chloroquine against SARS-COV-2 by effective binding with angiotensin converting enzyme-2 receptor: An insight from molecular docking and MD-simulation studies
por: Baildya, Nabajyoti, et al.
Publicado: (2021) -
Inhibitory efficacy of RNA virus drugs against SARS-CoV-2 proteins: An extensive study
por: Mandal, Manab, et al.
Publicado: (2021) -
Screening of potential drug from Azadirachta Indica (Neem) extracts for SARS-CoV-2: An insight from molecular docking and MD-simulation studies
por: Baildya, Nabajyoti, et al.
Publicado: (2021) -
Repurposing of anti-lung cancer drugs as multi-target inhibitors of SARS-CoV-2 proteins: An insight from molecular docking and MD-simulation study
por: Reza, Rahimasoom, et al.
Publicado: (2022)